Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Antimicrobial Chemotherapy|February 21, 2008
In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulationR Espada, S Valdespina, M A Dea, et al.
Tropical Biomedicine|February 9, 2021
Immunoproteomic analysis of Trichinella spiralis larval crude antigens recognized by sera from patients with trichinellosis after treatment with albendazoleM A Dea-Ayuela, M Sadkowska-Todys, J Wroblewski, et al.
Biomedical Chromatography : BMC|December 7, 2007
HPLC assay for determination of amphotericin B in biological samplesR Espada, J M Josa, S Valdespina, et al.
Tropical Medicine & International Health : TM & IH|September 14, 2004
Anti-leishmanial activity of a new formulation of amphotericin BM A Dea-Ayuela, S Rama-Iñiguez, J A Sánchez-Brunete, et al.
Journal of Drug Targeting|December 29, 2004
Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasisJ A Sánchez-Brunete, M A Dea, S Rama, et al.
Journal of Drug Targeting|July 30, 2005
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin BJ A Sánchez-Brunete, M A Dea, S Rama, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulationS Rama Iñiguez, M A Dea-Ayuela, J A Sanchez-Brunete, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheresJ A Sánchez-Brunete, M A Dea, S Rama, et al.
Die Pharmazie|February 15, 2018
IVIVC approach based on carbamazepine bioequivalence studies combinationI González-García, V Mangas-Sanjuan, M Merino-Sanjuán, et al.
International Journal of Pharmaceutics|March 2, 2023
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalersE de Pablo, P O'Connell, R Fernández-García, et al.
Pageof 3